As some readers know, in my pre-AlignMap life, three colleagues and I formed EnrichMap to develop a system for grouping patients according to their behavioral patterns pertinent to compliance. That information would allow customized, group-specific strategies to minimize unnecessary treatment failures caused by noncompliance. That decrease in treatment failures would, in turn, reduce the consequent morbidity and mortality, research confoundments, delays, and financial waste.
Our efforts resulted in the Emap Profile, a model that, based on an individual’s responses to a brief (20-25 items) questionnaire, divides the adult, cognitively-intact population into six segments, each with different implications for patient compliance:
- Sage and Satisfied
- Security Seeking
- Self Starting
- Uncertain and Concerned
- Spontaneous and Impulsive
- Vigilant and Suspicious
The problem was that we were unable to find a practical means of testing the tool.1 Consequently, we set the project aside. I began the AlignMap web site and blog, in fact, to provide an outlet for my continuing interest in treatment adherence.2
It now appears likely that my partners and I will be able to work with one of the companies involved in clinical trials to determine, in exchange for future considerations for their use of the this technology, if the Emap Profile does what we think it does.
And thus is reincarnation accomplished in the business world.
One manifestation of this corporate revitalization is the EnrichMap.com web site, which just came online. EnrichMap.com offers, naturally, more information about the Emap Profile, including the opportunity for a visitor to determine which of the six groups best describes his or her pattern of responses to healthcare instructions.
I’m posting about EnrichMap not only because I’m proud of that work but also because visitors to this site should know that I have a personal and financial interest in that service.
Information about EnrichMap and the Emap Profile is available at ~ EnrichMap ~
- “Practical means of testing the tool” translates into “a clinically and statistically valid method for testing our hypothesis that we could afford out of pocket.”↩
- Yes, if I had known we would be resuscitating EnrichMap, I might have chosen a name for this site other than “AlignMap,” which will inevitably be confused with “EnrichMap.”↩